Niosomes: A review on niosomal research in the last decade
P Bhardwaj, P Tripathi, R Gupta, S Pandey - Journal of Drug Delivery …, 2020 - Elsevier
In the last one-decade numbers of review and research, articles have been published on
niosomes. This shows the interest of researchers in niosomes because of the advantages …
niosomes. This shows the interest of researchers in niosomes because of the advantages …
Bilosomes nanocarriers for improved oral bioavailability of acyclovir: A complete characterization through in vitro, ex-vivo and in vivo assessment
Acyclovir (ACV) is an antiviral drug given as tablet that has variable and incomplete
absorption from the gastrointestinal tract. Also the absorption is saturated with multi-dose …
absorption from the gastrointestinal tract. Also the absorption is saturated with multi-dose …
Surface modified niosomes of olanzapine for brain targeting via nasal route; preparation, optimization, and in vivo evaluation
Olanzapine (OL) is an atypical antipsychotic drug which suffers from an extensive hepatic
metabolism and poor bioavailability. In addition, it has low brain permeability due to efflux by …
metabolism and poor bioavailability. In addition, it has low brain permeability due to efflux by …
[HTML][HTML] A stepwise optimization strategy to formulate in situ gelling formulations comprising fluconazole-hydroxypropyl-beta-cyclodextrin complex loaded niosomal …
H Elmotasem, GEA Awad - Asian journal of pharmaceutical sciences, 2020 - Elsevier
Fungal keratitis and endopthalmitis are serious eye diseases. Fluconazole (FL) is indicated
for their treatment, but suffers from poor topical ocular availability. This study was intended to …
for their treatment, but suffers from poor topical ocular availability. This study was intended to …
Niosomal delivery of simvastatin to MDA-MB-231 cancer cells
Objective The objective of this study was to use nano-niosomal formulations to deliver
simvastatin as a poor-water soluble drug into breast cancer cells. Significance Our study …
simvastatin as a poor-water soluble drug into breast cancer cells. Significance Our study …
[HTML][HTML] Development of provesicular nanodelivery system of curcumin as a safe and effective antiviral agent: statistical optimization, in vitro characterization, and …
Curcumin is a natural compound that has many medical applications. However, its low
solubility and poor stability could impede its clinical applications. The present study aimed to …
solubility and poor stability could impede its clinical applications. The present study aimed to …
In vitro characterization and release studies of combined nonionic surfactant-based vesicles for the prolonged delivery of an immunosuppressant model drug
A Rasul, M Imran Khan, M Ur Rehman… - International journal …, 2020 - Taylor & Francis
Background Cyclosporine A (CsA) is an exceptional immunosuppressant used for the
treatment of immune disorders. Niosomal vesicles are promising drug carriers that are …
treatment of immune disorders. Niosomal vesicles are promising drug carriers that are …
Preparation, characterization, and evaluation of the anticancer activity of artemether-loaded nano-niosomes against breast cancer
MJ Mirzaei-Parsa, MRH Najafabadi, A Haeri… - Breast Cancer, 2020 - Springer
Background The aim of this study was to develop nonionic surfactant vesicles (niosomes) as
a promising nanocarrier to enhance the anticancer activity of artemether. Methods The …
a promising nanocarrier to enhance the anticancer activity of artemether. Methods The …
Design and physicochemical characterization of lysozyme loaded niosomal formulations as a new controlled delivery system
Lysozyme loaded niosomes containing various molar ratios of two kinds of surfactants were
prepared and the properties of these niosomal formulations were studied. The results …
prepared and the properties of these niosomal formulations were studied. The results …
Formulation and evaluation of niosomal vesicles containing ondansetron HCL for trans-mucosal nasal drug delivery
MH Teaima, AM El Mohamady… - Drug development …, 2020 - Taylor & Francis
Ondansetron HCl is a (5-HT3) serotonin receptor antagonist, used as anti-emetic drug in
combination with anticancer agents. Conventional dosage forms have poor bioavailability …
combination with anticancer agents. Conventional dosage forms have poor bioavailability …